Literature DB >> 2577006

The ras family of oncogenes.

C J Der.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2577006     DOI: 10.1007/978-1-4613-1599-5_4

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  6 in total

1.  Biochemical characterization of baculovirus-expressed rap1A/Krev-1 and its regulation by GTPase-activating proteins.

Authors:  L A Quilliam; C J Der; R Clark; E C O'Rourke; K Zhang; F McCormick; G M Bokoch
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.

Authors:  Lothar Gremer; Torsten Merbitz-Zahradnik; Radovan Dvorsky; Ion C Cirstea; Christian Peter Kratz; Martin Zenker; Alfred Wittinghofer; Mohammad Reza Ahmadian
Journal:  Hum Mutat       Date:  2010-12-09       Impact factor: 4.878

Review 3.  Signal transduction from the extracellular matrix.

Authors:  R L Juliano; S Haskill
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

4.  Reversal of the Ras-induced transformed phenotype by HR12, a novel ras farnesylation inhibitor, is mediated by the Mek/Erk pathway.

Authors:  H Reuveni; T Geiger; B Geiger; A Levitzki
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

5.  Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1.

Authors:  Sheng Liu; Josephine Iaria; Richard J Simpson; Hong-Jian Zhu
Journal:  Cell Commun Signal       Date:  2018-03-13       Impact factor: 5.712

6.  The Novel Phosphatase Domain Mutations Q171R and Y65S Switch PTEN from Tumor Suppressor to Oncogene.

Authors:  Jose Antonio Ma G Garrido; Krizelle Mae M Alcantara; Joshua Miguel C Danac; Fidel Emmanuel C Serrano; Eva Maria Cutiongco-de la Paz; Reynaldo L Garcia
Journal:  Cells       Date:  2021-12-05       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.